Budesonide Clinical Trials

2 actively recruiting trials

▼ -1 trial since July 2026

Also known as: Pulmicort

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

Novartis Pharmaceuticals1
Maria Joyera Rodríguez1

Indications

Chronic Obstructive Pulmonary Disease1
Asthma1
COPD1

Other2 trials

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Phase 3

Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.